SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following a significant sell-off ignited by the recent disclosure of Nvidia's historical exit from its stock. This has polarized investors, with many dismissing the market reaction as headline-driven noise, pointing to APLD's robust fundamentals, continued institutional accumulation, and impending announcements of new hyperscaler contracts, in addition to its strategic cloud business spin-off.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after a major institutional investor significantly re-entered its position at higher prices following a previous sell-off, signaling a strong re-validation of its outlook, further bolstered by a recent Fast Track designation. The community is eagerly anticipating its upcoming Investor Day, where new clinical data and regulatory updates are expected to address perceived undervaluation and potentially fuel a short squeeze.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending due to a significant sell-off following its earnings, where a strong revenue beat was overshadowed by a lowered profit outlook for future quarters, sparking intense community debate around its valuation and whether AI poses a threat or tailwind for the cybersecurity sector.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is trending as the lack of communication regarding its Reproxalap proposed label following the February 16 deadline, coupled with its CDO's recent resignation and ongoing fraud lawsuits, leads bears to anticipate a third Complete Response Letter by March 16, while bulls view the FDA's earlier sharing of a draft label as a strong indicator of eventual approval.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending following its exclusive multi-year U.S. brewing partnership with Carlsberg, generating mixed community reactions as some investors express bullish excitement while others prioritize news regarding cannabis rescheduling, which continues to drive significant debate and short squeeze speculation within the sector.

Fiverr International Ltd. develops an e-commerce platform that allows people to buy and sell digital services. It operates through the following geographical segments: U.S., Europe, Asia Pacific, Rest of the World and Israel. The firm offers digital marketing, graphics and design, video and animation, writing and translation, and music and audio. The company was founded by Micha Kaufman and Shai Wininger in 2009 and is headquartered in Tel Aviv, Israel.

Fiverr International Ltd

Fiverr is trending after its recent earnings report included a weaker-than-expected FY26 revenue outlook and a strategic restructuring aiming to become an "AI-native" company. This has split community sentiment, with some viewing AI as an existential threat to the gig economy and others seeing deep undervaluation in a profitable company adapting for future growth.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE is trending due to its community's relentless "bag working" and conviction, actively promoting its status as an "OG meme" while highlighting the restoration of ragemaker.net. Members are vocal about their ambitious goal of reaching a multi-billion dollar valuation and securing major exchange listings.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge Technologies is soaring after revealing a collaboration with Infineon to develop high-efficiency power infrastructure for AI data centers, which has overshadowed mixed earnings results. The community is actively discussing a massive short squeeze as the stock pivots into the booming AI energy sector, sparking speculation of significant upside despite previous bearish sentiment on the solar industry.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion (INFQ) is trending following its SPAC merger and debut as a publicly traded company, with the company scheduled to ring the opening bell at the NYSE. The community is actively discussing its commercialized quantum sensing products, government contracts, and NVIDIA partnerships, comparing them favorably to sector peers and fueling conversations about its significant value proposition in the quantum technology space.

Analog Devices, Inc. is a semiconductor company, which engages in the combination of analog, digital, and software technologies into engineering solutions. Its products include analog and mixed signals, power management and reference, amplifiers radio frequency, and reference, sensors and actuators, and digital signal processing and system. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Analog Devices Inc.

Analog Devices is trending following a substantial earnings beat, robust guidance, an increased dividend, and a new share repurchase program, reinforcing management's view of a cyclical recovery. The community is actively discussing the company's strong, diversified growth across automotive, industrial, and AI-driven markets, prompting numerous analyst price target increases.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

What is Brookline Cap M's Estimate for CRSP Q1 Earnings?

CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) - Brookline Cap M issued their Q1 2026 earnings per share estimates for CRISPR Therapeutics in a report released on Thursday, February 12th...

Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss)

Key PointsCRISPR Therapeutics' fourth quarter was relatively disappointing...

VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales

Vertex Q4 earnings miss estimates, but revenues top forecasts on strong CF sales and momentum from new launches like Alyftrek, Casgevy and Journavx.

CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 8% on Analyst Upgrade

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 8% Following Analyst Upgrade...

CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates

CRISPR Therapeutics posts a wider Q4 loss and revenues miss, but Casgevy sales climb, with label expansion plans and pipeline updates ahead.

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $82.00

Needham & Company LLC raised their price objective on CRISPR Therapeutics from $80.00 to $82.00 and gave the stock a "buy" rating in a research note on Friday...

CRISPR Therapeutics (NASDAQ:CRSP) Announces Quarterly Earnings Results

CRISPR Therapeutics (NASDAQ:CRSP - Get Free Report) posted its earnings results on Thursday. The company reported ($1.37) earnings per share for the quarter, missing the consensus estimate of ($1.16...

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Lags Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of -18.85% and -78.42%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

CRISPR Therapeutics Earnings Report: Q4 Overview

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

CRSP
CRISPR Therapeutics AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CRSP News

CRSPCRISPR Therapeutics AG